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ABSTRACT 
 
Aims: HCV causes both acute and chronic infections and can be easily transmitted through 
contaminated blood or other body fluids. The present study deals with the molecular detection of 
HCV with help of one-step RT-PCR assay followed by nested PCR and agarose gel electrophoresis.   
Study Design: RNA extracted from the confirmed positive samples of HCV was utilized for the 
standardization of the one-step RT-PCR assay and nested PCR assay for diagnosis of HCV.  
Place and Duration of Study: Centre for Biotechnology, Maharshi Dayanand University, Rohtak 
Haryana, India, during period of one year (January-December 2015).  
Methodology: HCV positive samples were obtained from Department of Medicine, Maulana Azad 
Medical College (MAMC), New Delhi, India. Published primers from most conserved regions of HCV 
were taken and these primers were able to amplify all the strains of HCV. One-step RT-PCR kits, 
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primers, extracted RNA from these positive samples were used for standardization of molecular 
diagnostic assays. The results were checked by 2% agarose gel electrophoresis. 
Results: Positive samples of HCV were detected by nested PCR. Positive samples showed sharp 
band of 405bp while there was no amplification in the negative control.  
Conclusion: Rapid tests have low sensitivity and specificity while molecular assays are rapid, 
sensitive and specific. Conventional one-step RT-PCR assay followed by nested PCR is rapid, 
specific, sensitive and it is also less costly than real-time RT-PCR. Cost of an assay is an important 
factor in controlling a disease in resource limited settings of developing countries. 
 
 
Keywords: Hepatocellular carcinoma; conventional PCR; viral hepatitis; hepatitis C virus, one-step 
RT-PCR, nested PCR, molecular diagnosis. 
 
ABBREVIATIONS 
 
ELISA : Enzyme Linked Immunosorbent 
Assay 
HCV : Hepatitis C Virus  
RT-PCR : Reverse Transcriptase Polymerase 
Chain Reaction  
WHO : World Health Organization 
 
1. INTRODUCTION  
 
Hepatitis C Virus (HCV) is one of the important 
viruses among other hepatitis viruses (A, B, D, 
and E) which are responsible for serious chronic 
infection of liver. First case of HCV was reported 
in the serum of a patient with Non-A, Non-B 
hepatitis by Choo et al. in 1989 [1]. HCV is a 
small (50 nm), enveloped, single-stranded, 
positive-sense RNA virus of family Flaviviridae 
and genus Hepacivirus. Genome of HCV 
contains 9500 nucleotides with one open reading 
frame which encodes for about 3000 amino acid 
polypeptides [2]. HCV contains highly variable 
genome with more than six major genotypes of 
HCV which are circulating worldwide [3]. An 
estimate made by World Health Organization 
(WHO) showed that about 71 million people have 
chronic hepatitis and about 0.4 million people die 
each year due to cirrhosis and hepatocellular 
carcinoma [4]. Another study estimated the 
number of HCV infected people may be 150–200 
million globally [4,5,6]. The distribution pattern of 
HCV is not equal, with higher occurrence in 
developing part than the developed part of the 
world due to less health infrastructure and poor 
blood screening facilities. In India, there is no 
specific viral surveillance system, resulting in 
lack of exact data about HCV infections. 
Although some recent study estimated that 
prevalence of HCV is about 1.5% in India [5]. 
HCV is mainly spread by direct contact with 
infected blood or body fluids. HCV can be 
transmitted through the blood transfusion and 
items like contaminated needles, syringes or 
other medical equipment and needle-sharing 
among intravenous drug abusers [7]. Other 
social, cultural and behavioral practices (e.g., 
piercing, circumcision, tattooing) may become 
the reason for spreading of HCV, if inadequately 
sterilized equipments are used. Sexual 
transmission may also occur between partners 
although less frequently. Like HIV, HCV does not 
spread by sneezing, hugging, coughing, food or 
water, sharing eating utensils and casual contact 
[2,7,8,9]. HCV infections are broadly divided into 
acute and chronic types. Acute HCV occurs after 
an incubation period of 15 - 60 days with majority 
of acute HCV infections doesn’t show any 
symptoms [10]. Chronic HCV infections are less 
prevalent but more risky than acute infections 
and can cause liver cirrhosis and cancer in some 
cases. The clinical symptoms may vary from mild 
to life threatening. HCV patients show symptoms 
like malaise, vomiting, fatigue, lethargy, anorexia, 
abdominal pain, myalgia, jaundice, mild 
hepatosplenomegaly, maculopapular rash and 
arthralgia [2,5,7]. 
 
Clinically, we cannot differentiate HCV from other 
hepatitis viruses and precise diagnosis is 
possible with laboratory methods only. 
Laboratory diagnosis of HCV is done by 
conventional biochemical markers and liver 
function test (LFT) [2]. The most practical 
screening test for HCV infection is the enzyme 
linked immunosorbent assay (ELISA) but it has 
low sensitivity and specificity. Moreover, false 
positive ELISA results may occur in patients with 
autoimmune antibodies, paraproteinemia, EBV-
infection or other reasons [2,7,11,12]. Recently, 
few companies have introduced some rapid 
detection kits for HCV but these also struggle 
with poor sensitive and specificity issues. The 
reverse transcription polymerase chain reaction 
(RT-PCR) is the most used direct method to 
detect HCV RNA in blood [13,14]. Molecular 
assays are preferred for the confirmation of HCV 
infections because of their high sensitivity. But 
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HCV is a very slow replicating virus, containing 
low copy number and some RNA may be 
degraded during isolation process making 
conventional RT-PCR less sensitive. 
Conventional RT-PCR coupled with nested PCR 
has been used successfully for effective 
detection of HCV infections [15,16,17]. Real-time 
RT-PCR is another choice with high sensitivity 
and specificity but sophisticated equipments and 
costly reagents make the assay less economic 
for use in developing countries. As HCV is a 
highly dangerous virus having the capability to 
infect large segment of world population, the 
present study has been conceptualized to 
develop one-step RT-PCR assay followed by 
nested PCR for sensitive, specific and cost 
effective detection of HCV.  
 
2. MATERIALS AND METHODS  
 
2.1 Positive Samples of Hepatitis C Virus 
(HCV) 
 
HCV positive samples were obtained from the 
Department of Medicine, Maulana Azad Medical 
College (MAMC), New Delhi. At MAMC, these 
samples were positive for HCV by conventional 
RT-PCR and further confirmed by sequencing.  
 
2.2 RNA Extraction from Positive 
Samples  
 
Viral RNA was extracted from 200 µl of an 
aliquot of HCV positive sample. RNA extraction 
was done with the help of GeneJET Viral 
DNA/RNA Purification Kit (Thermo Fisher 
Scientific, USA) according to the manufacturer′s 
protocol. RNA was eluted with 50 µl of elution 
buffer and stored at −70°C  for further use. 
 
2.3 Standardization of One-step RT-PCR 
and Nested PCR for HCV Using 
Reference Strains 
 
First round of one-step RT-PCR was 
standardized using Verso 1-Step RT-PCR Kit 
(Thermo Fisher Scientific, USA) as per 
manufacturer’s instructions. Twenty five 
microliters of reaction mixture was prepared by 
adding 5 µl of extracted viral RNA and 0.2 µM of 
both outer forward and outer reverse primers into 
the master mixture. 5 µl of double distilled water 
was added into negative control. In One-Step 
RT-PCR assay, initially RT (conversion of RNA 
into cDNA) step was performed after that heat 
inactivation of RT enzyme was done followed by 
simple PCR steps. Second round of nested PCR 
was performed using 5 µl of amplicons of one-
step RT-PCR as template. The reaction mixture 
comprised of 2.5 µl of 10 × Taq buffer (Bangalore 
Genei) with 15 mM MgCl2, 0.2 mM of each 
dNTPs (Bangalore Genei), 0.2 µM of both 
internal forward and internal reverse primers and 
0.75 U Taq DNA polymerase (Bangalore Genei). 
Negative controls were also included in the 
assay.  
 
2.4 Primers for One-step RT-PCR and 
Nested PCR 
 
Published primers were selected from the 5’ 
UTR- core region of HCV which is conserved 
region for all serotypes and able to amplify all 
strains of HCV [18]. The specificity of these 
primers was also checked by BLAST 
(Bioinformatics tool/software) at NCBI site. 
Details of primers are given in Table 1. 
 
2.5 Agarose Gel Electrophoresis 
 
Nested PCR amplified products were visualized 
on 2.5% agarose gel. Agarose gel was prepared 
in 1X TAE (Tris acetate EDTA buffer, pH 8) 
buffer and the amplicons were loaded with the 
help of 2 µl of 1X gel loading dye (Bangalore 
Genei). Electrophoresis was performed for about 
60 min at a constant voltage of 80 V in running 
buffer containing 1X TAE and ethidium bromide 
(1 µg/ml). After electrophoresis gel was 
visualized in a gel documentation system or gel 
transilluminator. 
 
Table 1. External and internal primers used in one-step RT-PCR and nested PCR 
 
S. 
no. 
Primer name Sequences (5’-3’) Amplicon 
size (bp) 
Primer 
length 
Reference 
1 Outer Forward ACTGCCTGATAGGGTGCTTGCGAG  
631 
25  
[17] 2 Outer Reverse CCATGTACCATGAKRTCGGC 21 
3 Inner Forward  AGGTCTCGTAGACCGTGCATCATG  
405 
25 
4 Inner Reverse CAYGTRAGGGTATCGATGAC 21 
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3. RESULTS  
 
3.1 Optimization of One-step RT-PCR and 
Nested PCR 
 
One-step RT-PCR assay was standardized with 
0.2 µM of external forward & reverse primers. 
Optimum RNA template amount was found to be 
5 µl and 35 cycles were optimized for the one-
step RT-PCR assay. Optimal cyclic conditions for 
one-step RT-PCR assay are given in Table 2. 
 
Similarly nested PCR was also standardized by 
using 0.2 µM of internal forward & reverse 
primers and 5 µl of one-step RT-PCR product 
(first round). Negative controls were also 
included which contain 5 µl of nuclease free 
water in place of template DNA. Optimal cycling 
conditions for nested-PCR assay are given in 
Table 3.  
 
After nested PCR assay the amplified products 
were electrophoresed using 2.5% agarose gel 
and positive sample showed a sharp band of 405 
bp while there was no band in the negative 
controls (Fig. 1). 
 
3.2 Specificity of the Assay 
 
One-step RT-PCR and nested PCR assay were 
highly specific for HCV detection as these assays 
failed to detect RNA/DNA of other related 
hepatitis viruses (A, B, D and E). 
 
 
Fig. 1. Standardization of one step RT- PCR 
and nested PCR assay on HCV positive 
samples  
Lane 1,100 bp DNA marker; lane 2 and 3, HCV 
positive samples; lane 4 and 5, negative controls 
 
4. DISCUSSION 
 
Hepatitis C viruses are responsible for both    
acute and chronic infections of liver thereby 
affecting the large segment of global                     
population. Studies have shown that around 
150–200 million people are infected with acute     
or chronic liver ailments worldwide [4,5,6]. 
Currently, there is no vaccine available for                  
HCV but timely treatment with antiviral medicines 
can cure the disease. Thus a rapid, sensitive, 
specific and cost effective diagnosis of HCV 
plays a crucial role in the prophylaxis of the 
disease. 
 
Table 2. Thermal cycling conditions for one-step RT-PCR assay 
 
S. no. Steps Temperature (ºC) Time 
1 Reverse transcription 50 60 Min 
2 Heat inactivation 95 15 Min 
3 Initial denaturation 95 03 Min 
4 Denaturation 95 45 Sec 
5 Annealing 50 45 Sec 
6 Extension 72 45 Sec 
7 Final extension 72 07 Min 
8 Storage  4 ∞ 
9 Number of cycle 35 Cycle (step 4-6) 
 
Table 3. Optimal cycling conditions for nested-PCR assay 
 
S. no. Steps Temperature (ºC) Time 
1 Initial denaturation 95 03 Min 
2 Denaturation 95 45 Sec 
3 Annealing 50 45 Sec 
4 Extension 72 45 Sec 
5 Final extension 72 07 Min 
6 Storage  4 ∞ 
7 Number of cycle 35 Cycle (step 2-4) 
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Presently HCV is diagnosed by rapid commercial 
kits, ELISA, biochemical marker, RT-PCR and 
real-time RT-PCR. ELISA and rapid commercial 
kits have low sensitivity and specificity for 
different hepatitis virus strains and can generate 
false positive results [2,7,11,12]. PCR based 
assays are the most direct approach to detect 
HCV RNA in blood [13-15]. Confirmed virus 
detection and typing could be possible by virus 
isolation but absence of virus isolation in cell 
culture hampers the research on HCV. Molecular 
detection methods are replacing traditional virus 
culture methods as these are more rapid, 
sensitive and specific [18-22]. Molecular 
diagnostic assays are more reliable than virus 
isolation and rapid kits. Conventional RT-PCR, 
real-time RT-PCR, transcription mediated 
amplification and branched DNA based assays 
are the most common molecular methods used 
for the detection and quantification of HCV 
[23,24].  
 
In the present study HCV diagnosis was done by 
one-step RT-PCR assay followed by nested 
PCR. This method was based on two rounds of 
PCR amplification thereby increasing the 
detection time but the sensitivity and specificity of 
the assay was high. As HCV is a very slow 
growing virus and producing small number of 
virion particles per cell, hence we need nested 
types of PCR to produce the enough DNA to be 
detected. Amplified products can be seen in the 
agarose gel after staining with ethidium bromide. 
According to literature, nested RT-PCR assay 
demonstrated comparable sensitivity and 
specificity when compared to other methods like 
real-time RT-PCR. Real time RT-PCR approach 
although considered as more rapid, sensitive and 
specific but too expensive for large-scale 
diagnosis and has not been widely used in the 
majority of clinical laboratories in developing 
countries [13-15,21-23]. The primer sequences 
used as external and internal primers in the 
assay were highly conserved and specific for 
HCV only making the assay non-specific for 
other related viruses like hepatitis A,B,D and E. 
This assay can be used as diagnostic tool for 
clinicians and also can be used for 
epidemiological surveillance studies and 
screening blood donors and would be suitable for 
any resource limited setup. 
  
5. CONCLUSION 
 
In the present study, a specific, sensitive and 
cost effective diagnostic assay for HCV was 
developed. Presently, HCV is detected by simple 
biochemical assays, rapid tests and modern 
molecular assays. Rapid tests have low 
sensitivity and specificity while molecular assays 
like real-time PCR are more rapid, sensitive and 
specific but costly. Cost of a diagnostic assay is 
an important factor in the developing countries 
like India. Non-availability of effective vaccines 
and antivirals make HCV infections more 
dangerous and a major problem world-wide. The 
present diagnostic assay was standardized using 
confirmed positive reference samples of HCV 
virus. The RT-PCR coupled nested PCR assay 
can be applied directly on HCV suspected 
patients’ samples providing sensitive, specific, 
rapid and cost effective result within the 
reasonable time and cost. There is still a need to 
develop some therapeutic agents and vaccines 
against HCV infections. The present assay can 
be modified in multiplex format according to the 
need of time.  
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